Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03630770 · ClinicalTrials.gov registry record · Phase 1
Effect of Medium Chain Triglyceride Intake on Colonization of Preterm Infants With Candida
A Phase 1 study of Premature Infant and Candida Infection, sponsored by Joseph Bliss.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT03630770: Completed Phase 1 study of Premature Infant and Candida Infection, sponsored by Joseph Bliss.
NCT03630770 is a Phase 1 study of Premature Infant and Candida Infection that has completed, run by Joseph Bliss. The registered enrollment target is 12 participants, below the 289-participant average among 9 other Premature Infant trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03630770, a Phase 1 study of Premature Infant and Candida Infection, has completed, sponsored by Joseph Bliss.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates whether adding a dietary supplement similar to coconut oil (MCT oil) to feedings in premature infants will reduce the amount of yeast (Candida) detectable in their stool. Infants who have Candida in their stool are eligible to participate. Half of the enrolled infants will have additional MCT oil added to their feedings and half will not.
Primary Outcome
Change in colony-forming units (cfu) of Candida per gram of stool. Data table reflects total number of stool samples collected from subjects in each group that were included in the analysis.
Conditions Studied
Interventions
- DRUG Medium-Chain Triglyceride (MCT) Oil
Study Locations (1)
Rhode Island
- Women & Infants Hospital of Rhode Island - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2014-06-05 |
| Est. Completion | 2021-11-02 |
| Phase | Phase 1 |
What the finished NCT03630770 record still lists
NCT03630770 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 289-participant average among 9 other Premature Infant trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Premature Infant appearing as the primary indexed condition, and to 1 intervention - of which Medium-Chain Triglyceride (MCT) Oil is the first listed.
NCT03630770 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT03630770 about?
NCT03630770 is a clinical study titled "Effect of Medium Chain Triglyceride Intake on Colonization of Preterm Infants With Candida". This study evaluates whether adding a dietary supplement similar to coconut oil (MCT oil) to feedings in premature infants will reduce the amount of yeast (Candida) detectable in their stool. Infants who have Candida in their stool are eligible to participate. Half of the enrolled infants will have ...
What is the current status of trial NCT03630770?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2014-06-05. Estimated completion is 2021-11-02.
What conditions does trial NCT03630770 study?
This clinical trial studies the following conditions: Premature Infant, Candida Infection.
What interventions are being tested in trial NCT03630770?
The interventions under investigation include: Medium-Chain Triglyceride (MCT) Oil (DRUG).
Who is sponsoring clinical trial NCT03630770?
This trial is sponsored by Joseph Bliss, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03630770 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Premature Infant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03630770's enrollment target sits among peer trials
12 10th of 9 the lowest of 9 other Premature Infant trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Premature Infant trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Genesis Electrical Impedance Tomography (EIT): A Preliminary Study
RECRUITING
-
Preventing Vulnerable Child Syndrome in the NICU With Cognitive Behavioral Therapy (PreVNT Trial)
RECRUITING · NA
-
Growing Little PEAPODS Study
RECRUITING
-
Cycled Phototherapy
ACTIVE NOT RECRUITING · NA
-
Cincinnati Infant Neurodevelopment Early Prediction Study (CINEPS)
ACTIVE NOT RECRUITING
-
Ultrasound Assessment of BC in the NICU
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI